Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: Primary care

ACR’s Community Practice Council Supports Independent Practitioners

Dana Elise Rockwell, DO  |  October 12, 2023

Forging one’s own path after completing medical training can be daunting. As I entered the final six months of my rheumatology fellowship, I was also pregnant with my first child. Having grown comfortable within academic settings, I felt the nerves of trying to find my place outside medical education. Search for Home For the best…

Filed under:Practice Support Tagged with:Community Practice Councilindependent practicePrivate practice

Your Invitation Here: Learn How Advocacy Can Help You & Your Practice

From the College  |  October 9, 2023

Learn how ACR staff and volunteers support the interests of the rheumatology community in public policy efforts related to Medicare reimbursement, step therapy reform, drug pricing, supporting the medical workforce and more.

Filed under:ACR ConvergenceLegislation & Advocacy Tagged with:ACR Convergence 2023

RheumMadness 2023: The Results Are In

David L. Leverenz, MD, MEd  |  September 11, 2023

RheumMadness is an online tournament in which a bracket of teams, representing key learning concepts in rheumatology, compete against each other in a series of head-to-head matchups, much like basketball teams in the NCAA’s March Madness. The 2023 tournament theme was The All Star Season. Each team represented one all star article competing to be…

Filed under:Career DevelopmentConditionsEducation & TrainingProfessional TopicsResearch ReviewsResearch RheumRheumatoid ArthritisVasculitis Tagged with:AAV FocusRheumANCA-Associated VasculitisAntibodiescyclophosphamideetanerceptFellowsFellows-in-TrainingGlucocorticoidsonline educationpreclinicalprednisoneRheumatology Research FoundationRheumMadnessrituximabTNF-Alpha inhibitor

Ignite the Spark of Joy & Discovery

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  September 9, 2023

A Roshi (i.e., master) apparently said that in Zen, “there is nothing to believe and everything to discover.” Interestingly enough, I have never been able to confirm who actually said that, which makes this saying about belief and discovery particularly apt. Regardless, I think about those words at least twice a day when I am…

Filed under:Career DevelopmentEducation & TrainingOpinionProfessional TopicsRheuminations

A Novel Study Compared the Effectiveness of Adalimumab with Tofacitinib in RA

Samantha C. Shapiro, MD  |  August 17, 2023

Your patient with rheumatoid arthritis (RA) isn’t responding well enough to methotrexate, and you both agree it’s time to consider a biologic or targeted synthetic disease-modifying anti-rheumatic drug (DMARD). But which one should you choose? In a treat-to-target era, we’re fortunate to have a variety of RA therapies at our disposal. Clinical practice guidelines from…

Filed under:Biologics/DMARDsConditionsDrug UpdatesRheumatoid Arthritis Tagged with:adalimumabDisease-modifying antirheumatic drugs (DMARDs)Rheumatoid Arthritis (RA)Tofacitinib

3 AC&R Study Summaries: Fractures in Patients with SSc, Clinical Response in JIA, & TV & the Public Perception of Gout

Arthritis Care & Research  |  August 13, 2023

Fractures in Patients with SSc By Zsuzsanna McMahan, MD, MHS Why was this study done? To minimize disability due to systemic sclerosis (SSc), it’s important to prevent and manage complications. Many SSc complications and related medications may increase the risk for osteoporosis and fracture. We sought to identify modifiable risk factors for fracture in patients…

Filed under:ConditionsGout and Crystalline ArthritisPatient PerspectivePractice ManagementResearch ReviewsResearch RheumSystemic Sclerosis Tagged with:juvenile idiopathic arthritis (JIA)polyarticular juvenile idiopathic arthritis (JIA)Reading Rheumsystemic sclerosis (SSc)

Rheuminations: Why I Don’t Use the Term ‘Stakeholder’

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  August 13, 2023

Modern healthcare is, for better or for worse, the hybrid of many different fields—some that are expected, such as biomedical science, and others that are less well appreciated, such as astrology and palmistry. One modern contributor to healthcare is management. Nowadays, we’re inundated with all sorts of jargon from the business and policy worlds: turnover,…

Filed under:OpinionProfessional TopicsRheuminations Tagged with:DiversityEquityinclusion

What Patients with Lupus Want You to Know

Jacqueline Jansz, MD, with Nadera Sweiss, MD  |  August 11, 2023

During a series of interviews with patients who have systemic lupus erythematosus, issues related to medication side effects, supplement use, depression and support groups arose, as well as concerns about race and activities of daily living. The interviews gave me a better understanding of what patients with lupus wish their physicians knew. I am grateful…

Filed under:ConditionsPatient PerspectivePractice ManagementSystemic Lupus Erythematosus Tagged with:dietary supplementMental Healthside effect

Measuring Up: A Review of the ACR-Owned Quality Measures

Allison Plitman, MPA  |  July 25, 2023

Since 2006, the Centers for Medicaid & Medicare Services (CMS) has increasingly driven clinicians to focus on and improve quality. Quality measures help clinicians measure how well they treat their patients. By tracking their performance, clinicians can identify opportunities to improve patient care while meeting federal reporting requirements. Breaking Down Quality Measures The CMS has…

Filed under:Uncategorized

Tigulixostat Promising for Patients with Gout & Hyperuricemia

Arthritis & Rheumatology  |  June 28, 2023

In a dose-finding, clinical trial, Terkeltaub et al. examined the safety and efficacy of tigulixostat, a nonpurine xanthine oxidase inhibitor, for lowering the serum urate levels of patients with gout and hyperuricemia.

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:Arthritis & RheumatologyGoutGout Resource CenterhyperuricemiaResearchserum urate levelstigulixostat

  • « Previous Page
  • 1
  • …
  • 69
  • 70
  • 71
  • 72
  • 73
  • …
  • 137
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences